TCPL Packaging Q1 FY27: consolidated PAT surges 79% YoY to ₹40 Cr, margins expand
PAT +79.26% YoY · revenue +16.08% · margins expanding
₹492.97 Cr
+16.08% YoY
₹40.01 Cr
+79.26% YoY
8.08%
+2.8pp YoY
₹43.96
TCPL Packaging's consolidated revenue came in at ₹492.97 Cr, up 16.1% YoY (₹424.68 Cr) and 8.6% QoQ (₹453.83 Cr), while PAT jumped 79.3% YoY to ₹40.01 Cr (₹22.32 Cr) and 84.2% QoQ (₹21.72 Cr); basic EPS rose to ₹43.96 from ₹24.52 a year ago. Standalone PAT was ₹37.63 Cr, up 65.6% YoY. Neither the current nor the year-ago quarter carried an exceptional item (unlike the March-26 quarter's ₹2.22 Cr Labour Code provision), so this growth is clean and not inflated by base-effect one-offs.
Q1 FY-2027 vs prior quarters
Net margin expanded to 8.1% from 5.3% YoY (4.8% QoQ), and EBITDA rose 18.4% to ₹85.95 Cr with margin at 17.4% versus 17.1% YoY and 15.3% QoQ. But the margin bridge is not purely operational: of the ₹23.84 Cr YoY increase in PBT, roughly ₹13 Cr came from operating leverage (revenue growing faster than ex-finance, ex-depreciation opex) while roughly ₹14.2 Cr came from finance costs nearly halving (₹26.44 Cr to ₹12.28 Cr) — pointing to debt reduction rather than an equivalent jump in core profitability.
The stock went into the print at ₹3,820, up 25.7% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records.
Management expects continued healthy double-digit domestic growth to be a key driver. While export volumes remain subdued, recent trade deals with the US and EU are anticipated to gradually improve sentiment and create a more favorable operating environment over time, though significant ramp-up will take months. The co
— This quarter: met
No reliable Street consensus estimates for this print turned up in search — small/mid-cap coverage gap — so vs-Street is unknown. Against management's own February-2026 guidance of "continued healthy double-digit domestic growth" and roughly ₹100 Cr FY27 capex, the double-digit consolidated topline is on track, though the filing gives no domestic/export split (single-segment reporting) to verify the specific domestic mix flagged then. Separately, on the same day, the board approved a new line of business — lithium-ion battery separator films for EV and grid-storage cells — earmarking roughly ₹125 Cr over 18 months with commercial production targeted for Q4 FY2028; this sits outside the core packaging capex programme guided earlier. Management's press release called the quarter "broad-based and profitable growth" with EBITDA +17% and cash profit +56%, both directionally consistent with the filing's EBITDA growth of 18.4%.
W1
New lithium-ion battery separator film unit — ~₹125 Cr capex over 18 months, commercial production targeted Q4 FY2028; watch execution and customer-qualification progress
W2
FY27 core capex guided at ~₹100 Cr (Feb-2026 concall) now layered with the new EV separator-film investment — track quarterly capex and funding mix
W3
Finance cost run-rate — nearly halved YoY to ₹12.28 Cr this quarter and drove ~60% of the PBT increase; watch whether this holds or reverses as new capex draws fresh borrowing
Informational and educational content only. Not investment advice.